Aldosterone induces angiotensin converting enzyme (ACE) gene expression via JAK2-dependent pathway in rat endothelial cells

Endocrinology

Volumn 146, Issue 9, 2005, Pages 3900-3906

  Sugiyama, Toru ^a   Yoshimoto, Takanobu ^a   Tsuchiya, Kyoichiro ^a   Gochou, Naoki ^a   Hirono, Yuki ^a   Tateno, Toru ^a   Fukai, Nozomi ^a   Shichiri, Masayoshi ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ACE; Aldosterone; Endothelial cell; JAK2; PTK

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 6,7 DIMETHOXY 2 PHENYLQUINOXALINE; ALDOSTERONE; DACTINOMYCIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GENISTEIN; GLUCOCORTICOID RECEPTOR ANTAGONIST; HIPPURYLHISTIDYLLEUCINE; JANUS KINASE 2; JANUS KINASE INHIBITOR; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN TYROSINE KINASE INHIBITOR; SPIRONOLACTONE;

ANIMAL CELL; BLOOD VESSEL INJURY; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UPREGULATION;

ALDOSTERONE; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; JANUS KINASE 2; MALE; PEPTIDYL-DIPEPTIDASE A; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER;

EID: 23844528209     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1674     Document Type: Review

References (45)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Prez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
2. Pitt B, Remme WJ, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
3. Rocha R, Stier CT, Jr. 2001 Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 12:308-314
4. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol 283:H1802-1810
5. Rocha R, Funder JW 2002 The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 970:89-100
6. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ 1996 Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767
7. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ 1991 Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69:475-482
8. Hokimoto S, Yasue H, Fujimoto K, Sakata R, Miyamoto E 1995 Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res 29:664-669
9. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H 1994 Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 94:301-310
10. Xiao F, Puddefoot JR, Barker S, Vinson GP 2004 Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation. Hypertension 44:340-345
11. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC 2004 Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109:2792-2800
12. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Kuwahara K, Saito Y, Nakao K, Ogawa H 2001 Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104:137-139
13. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, kerr IM 1993 Complementation by the protein tyrosin kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 366:166-170
14. Xu JW, Ikeda K, Yamori Y 2004 Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27:675-683
15. Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney JF Jr. 2005 Cytokine-stimulated GTP cyclohydrolase i expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ Res 96:164-171
16. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA 1996 Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271:695-701
17. Sandberg EM, Sayeski PP 2004 Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells. J Biol Chem 279:34547-34552
18. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC 2004 Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109:2792-2800
19. Jung F, Haendeler J, Hoffmann J, Reissner A, Dernbach E, Zeiher AM, Dimmeler S 2002 Hypoxic induction of the hypoxis-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res 91:38-45
20. McGuire PG, Orkin RW 1987 Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata. Lab Invest 57:94-105
21. Shichiri M, Hirata Y 2001 Antiangiogenesis signals by endostatin. FASEB J 15:1044-1053
22. Yoshimoto T, Fukai N, Sato R, Sugiyama T, Ozawa N, Shichiri M, Hirata Y 2004 Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145:3331-3337
23. Cushman DW, Cheung HS 1971 Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20:1637-1648
24. Shichiri M, Kato H, Doi M, Marumo F, Hirata Y 1999 Induction of max by adrenomedullin and CGRP antagonizes endothelial apoptosis. Mol Endocrinol 13:1353-1363
25. Shichiri M, Yokokura M, Marumo F, Hirata Y 2000 Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 20:989-997
26. Young MJ, Moussa L, Dilley R, Funder JW 2003 Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β -hydroxysteroid dehydrogenase inactivation. Endocrinology 144:1121-1125
27. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
28. Oberleithner H, Schneider SW, Albermann L, Hillebrand U, Ludwig T, Riethmuller C, Shahin V, Schafer C, Schillers H 2003 Endothelial cell swelling by aldosterone. J Membr Biol 196:163-172
29. Oberleithner H, Ludwig T, Riethmuller C, Hillebrand U, Albermann L, Schafer C, Shahin V, Schillers H 2004 Human endothelium: target for aldosterone. Hypertension 43:952-956
30. Rousseau MF, Gurne O, Duprez D, Van Mieghem W, Robert A, Ahn S, Galanti L, Ketelslegers JM; Belgian RALES Investigators 2002 Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol 40:1596-1601
31. Karim A, Zagarella J, Hutsell TC, Dooley M 1976 Spironolactone. III. Canrenone-maximum and minimum steady-state plasma levels. Clin Pharmacol Ther 19:177-182
32. Fuller PJ, Lim-Tio SS, Brennan FE 2000 Specificity in mineralocorticoid versus glucocorticoid action. Kidney Int 57:1256-1264
33. Smith RE, Little PJ, Maguire JA, Stein-Oakley AN, Krozowski ZS 1996 Vascular localization of the 11beta-hydroxysteroid dehydrogenase type II enzyme. Clin Exp Pharmacol Physiol 23:549-551
34. Brem AS, Bina RB, King TC, Morris DJ 1998 Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension 31:459-462
35. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C 1998 Myocardial production of aldosterone and corticosterone in the rat. J Biol Chem 273:4883-4891
36. Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R 1996 Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab 81:2797-2800
37. Xiao F, Puddefoot JR, Vinson GP 2000 Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation. J Endocrinol 165:533-536
38. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R 1994 Synthesis of corticosterone in the vascular wall. Endocrinology 138:3369-3373
39. Ahmad N, Romero DG, Gomez-Sanchez EP, Gomez-Sanchez CE 2004 Do human vascular endothelial cells produce aldosterone? Endocrinology 145:3626-3629
40. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE 2004 Origin of aldosterone in the rat heart. Endocrinology 145:4796-4802
41. Funder JW 2004 Cardiac synthesis of aldosterone: going, going, gone...? Endocrinology 145:4793-4795
42. Merrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE 1995 Direct stimulation of JAK/STAT pathway by the angiotensin II AT1 receptor. Nature 375:247-250
43. Schindler C 1999 Cytokines and JAK-STAT signaling. Exp Cell Res 253:7-14
44. Sayeski PP, Ali MS, Hawks K, Frank SJ, Bernstein KE 1999 The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src. Circ Res 84:1332-1338
45. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T 1998 Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896